⌘K

Home/Filings/4/0000950170-25-023436

4//SEC Filing

Apeiron Investment Group Ltd. 4

Accession 0000950170-25-023436

CIK 0001840904other

View on SEC.gov Company Profile

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 6:00 PM ET

Size

6.9 KB

Accession

0000950170-25-023436

Insider Transaction Report

Form 4

Period: 2025-02-14

ATAI Life Sciences N.V.ATAI

Apeiron Investment Group Ltd.

10% Owner

Transactions

Purchase
Common Shares
2025-02-14$2.10/sh+10,835,718$22,755,008→ 40,555,215 total(indirect: By Apeiron Investment Group Ltd.)

Holdings

Common Shares
(indirect: By Apeiron Presight Capital Fund II, L.P.)
1,799,302

Angermayer Christian

Director10% Owner

Transactions

Purchase
Common Shares
2025-02-14$2.10/sh+10,835,718$22,755,008→ 40,555,215 total(indirect: By Apeiron Investment Group Ltd.)

Holdings

Common Shares
(indirect: By Apeiron Presight Capital Fund II, L.P.)
1,799,302

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

ATAI Life Sciences N.V.

CIK 0001840904

Entity typeother

IncorporatedMalta

Related Parties

1

filerCIK 0001845711

Filing Metadata

Form type: 4
Filed: Feb 18, 7:00 PM ET
Accepted: Feb 19, 6:00 PM ET
Size: 6.9 KB

View on SEC.gov